Table 2 Comparison between patients with and without neoadjuvant chemotherapy
From: Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy
Variables |  | Neoadjuvant chemotherapy (n = 7) | No neoadjuvant chemotherapy (n = 33) | p |
|---|---|---|---|---|
Age (median, IQR, months) | Â | 43.0 (12.0, 77.0) | 40.0 (18.0, 94.0) | 0.8100 |
Tumor size (at diagnosis) (median, IQR, cm) |  | 10.5 (7.8, 13.3) | 5.6 (4.6,6.5) |  < 0.0001 |
Hormonal disorder | Yes | 5 (71.4) | 26 (78.8) | – |
| Â | No | 0 | 1 (3.0) | Â |
| Â | Missing data | 2 (28.6) | 6 (18.2) | Â |
ENSAT stage | I | 0 | 14 | – |
| Â | II | 1 | 15 | Â |
| Â | III | 3 | 4 | Â |
| Â | IV | 3 | 0 | Â |